SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: GregSL who wrote (738)2/16/2000 10:54:00 AM
From: LORD ERNIE  Respond to of 857
 
I mean they have the same laws so the aproval should be in the first months. 1 year after filing.



To: GregSL who wrote (738)2/16/2000 1:37:00 PM
From: Scott  Read Replies (1) | Respond to of 857
 
If Ampligen gets fast track designation from the FDA, as is likely given the lack of current treatment options for CFA, a decision will come about 6 months after filing.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News